SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout


Uric acid is the end product of purine metabolism in humans and great apes, which have lost hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200–500 μM) compared with other mammals (3–120 μM)1. About 70% of daily urate disposal occurs via the kidneys, and in 5–25% of the human population, impaired renal excretion leads to hyperuricemia2. About 10% of people with hyperuricemia develop gout, an inflammatory arthritis that results from deposition of monosodium urate crystals in the joint. We have identified genetic variants within a transporter gene, SLC2A9, that explain 1.7–5.3% of the variance in serum uric acid concentrations, following a genome-wide association scan in a Croatian population sample. SLC2A9 variants were also associated with low fractional excretion of uric acid and/or gout in UK, Croatian and German population samples. SLC2A9 is a known fructose transporter3, and we now show that it has strong uric acid transport activity in Xenopus laevis oocytes.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Association of SLC2A9 SNPs with SUA (−log10 P values) following a genome-wide association scan of 794 Croatians using 308,140 SNPs.
Figure 2: SLC2A9 shows saturable [8-14C]uric acid transport activity in Xenopus laevis oocytes.

Accession codes




  1. 1

    Johnson, R.J., Titte, S., Cade, J.R., Rideout, B.A. & Oliver, W.J. Uric acid, evolution and primitive cultures. Semin. Nephrol. 25, 3–8 (2005).

    CAS  Article  PubMed  Google Scholar 

  2. 2

    Becker, M.A. & Jolly, M. Hyperuricemia and associated diseases. Rheum. Dis. Clin. North Am. 32, 275–293 (2006).

    Article  PubMed  Google Scholar 

  3. 3

    Manolescu, A.R., Augustin, R., Moley, K. & Cheeseman, C. A highly conserved hydrophobic motif in the exofacial vestibule of fructose transporting SLC2A proteins acts as a critical determinant of their substrate selectivity. Mol. Membr. Biol. 24, 455–463 (2007).

    CAS  Article  PubMed  Google Scholar 

  4. 4

    Campbell, H. et al. Effects of genome-wide heterozygosity on a range of biomedically relevant human quantitative traits. Hum. Mol. Genet. 16, 233–241 (2007).

    CAS  Article  PubMed  Google Scholar 

  5. 5

    Aulchenko, Y.S., de Koning, D.J. & Haley, C. Genomewide rapid association using mixed model and regression: a fast and simple method for genomewide pedigree-based quantitative trait loci association analysis. Genetics 177, 577–585 (2007).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. 6

    Graessler, J. et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum. 54, 292–300 (2006).

    CAS  Article  PubMed  Google Scholar 

  7. 7

    Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., Smith, S.C. Jr. & Lenfant, C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433–438 (2004).

    Article  PubMed  Google Scholar 

  8. 8

    Choi, H.K. & Ford, E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am. J. Med. 120, 442–447 (2007).

    Article  PubMed  Google Scholar 

  9. 9

    Ford, E.S., Li, C., Cook, S. & Choi, H.K. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 115, 2526–2532 (2007).

    CAS  Article  PubMed  Google Scholar 

  10. 10

    Seatter, M.J., De la Rue, S.A., Porter, L.M. & Gould, G.W. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site. Biochemistry 37, 1322–1326 (1998).

    CAS  Article  PubMed  Google Scholar 

  11. 11

    Uldry, M. & Thorens, B. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch. 447, 480–489 (2004).

    CAS  Article  PubMed  Google Scholar 

  12. 12

    Phay, J.E., Hussain, H.B. & Moley, J.F. Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 66, 217–220 (2000).

    CAS  Article  PubMed  Google Scholar 

  13. 13

    Augustin, R. et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J. Biol. Chem. 279, 16229–16236 (2004).

    CAS  Article  PubMed  Google Scholar 

  14. 14

    Keembiyehetty, C. et al. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol. Endocrinol. 20, 686–697 (2006).

    CAS  Article  PubMed  Google Scholar 

  15. 15

    Richardson, S. et al. Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 11, 92–101 (2003).

    CAS  Article  PubMed  Google Scholar 

  16. 16

    Enomoto, A. & Endou, H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin. Exp. Nephrol. 9, 195–205 (2005).

    CAS  Article  PubMed  Google Scholar 

  17. 17

    Hagos, Y., Stein, D., Ugele, B., Burckhardt, G. & Bahn, A. Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J. Am. Soc. Nephrol. 18, 430–439 (2007).

    CAS  Article  PubMed  Google Scholar 

  18. 18

    Mount, D.B., Kwon, C.Y. & Zandi-Nejad, K. Renal urate transport. Rheum. Dis. Clin. North Am. 32, 313–331 (2006).

    Article  PubMed  Google Scholar 

  19. 19

    Heinig, M. & Johnson, R.J. Role of uric acid in hypertension, renal disease, and metabolic syndrome. Cleve. Clin. J. Med. 73, 1059–1064 (2006).

    Article  PubMed  Google Scholar 

  20. 20

    Emmerson, B.T. Effect of oral fructose on urate production. Ann. Rheum. Dis. 33, 276–280 (1974).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  21. 21

    Rutledge, A.C. & Adeli, K. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr. Rev. 65, S13–S23 (2007).

    Article  PubMed  Google Scholar 

  22. 22

    Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23

    Wallace, C. et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet. 82, 139–149 (2008).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  24. 24

    Rudan, I. et al. Effects of inbreeding, endogamy, genetic admixture, and outbreeding on human health: a (1001 Dalmatians) study. Croat. Med. J. 47, 601–610 (2006).

    PubMed  PubMed Central  Google Scholar 

  25. 25

    Kimber, C.H. et al. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels. Diabetologia 50, 1186–1191 (2007).

    CAS  Article  PubMed  Google Scholar 

  26. 26

    Morris, A.D. et al. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet 350, 1505–1510 (1997).

    CAS  Article  PubMed  Google Scholar 

  27. 27

    Wallace, S.L. et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum. 20, 895–900 (1977).

    CAS  Article  PubMed  Google Scholar 

  28. 28

    Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  29. 29

    Gray, N.K., Coller, J.M., Dickson, K.S. & Wickens, M. Multiple portions of poly(A)-binding protein stimulate translation in vivo. EMBO J. 19, 4723–4733 (2000).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. 30

    Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225–2229 (2002).

    CAS  Article  PubMed  Google Scholar 

Download references


This research was funded by grants from the Medical Research Council (UK), the Wellcome Trust, Arthritis Research Campaign (S.H.R.), and Cancer Research UK (A.T.), an MRC Senior Non-Clinical Fellowship (N.K.G.), and Republic of Croatia Ministry of Science, Education and Sports grants to I.R. (108-1080315-0302), P.R. (196-1962766-2751), B.J. (196-1962766-2763) and N.S.-N. (196-1962766-2747). The Croatian and Scottish (Orcadian) groups are now components of the EU Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) (I.R., H.C., J.F.W., A.F.W., N.D.H.). We thank G.W. Gould, C.I. Cheeseman and I. White for helpful discussions and advice. We acknowledge the Wellcome Trust Clinical Research Facility (Edinburgh) for performing DNA extractions (Orkney) and the genome-wide association scan, J. Ireland for computing support and C. Nicol for the figures. Special thanks to K. Wilson and R. Bisset for administrative support.

Author information




H.C., I.R., N.D.H. and A.F.W. designed the study and wrote the paper. V.V., C.H., J.F., S.A.K., A.T. and P.M.M. performed statistical analyses. S.C. and J.M. carried out the genotyping. N.K.G., X.S., B.G., W.A.R. and P.H. made constructs and performed transporter assays. P.R., I.K., O.P., B.J., N.S.-N., Z.B., L.B.-L., M.P., I.M.K., L.Z. and T.S.-J. performed field work and constructed genealogies in Croatia. J.F.W. and S.H.W. provided replication in Orcadian samples. J.G., M.A., P.L.R., S.H.R., A.M. and L.D.F. provided gout and FEUA samples. C.N.A.P., C.H.K., L.A.D. and A.D.M. genotyped and analyzed the Go-DARTS dataset.

Corresponding author

Correspondence to Alan F Wright.

Ethics declarations

Competing interests

We have filed a patent application based on this work.

Supplementary information

Supplementary Text and Figures

Supplementary Figure 1, Supplementary Tables 1–4 (PDF 90 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Vitart, V., Rudan, I., Hayward, C. et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40, 437–442 (2008).

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing